Biosimilar Interchangeability Designation Would Be Nixed Under Biden Proposal

 
• By Derrick Gingery
budget
The FDA would receive about $7.2bn in budget authority and user fees in Biden's FY 2025 budget request. • Source: Shutterstock

More from Biosimilars

More from Biosimilars & Generics